drugset / Trial / NCT03718039
Phase 2 Bunionectomy HTX-011 Administration Study
Non-randomizedSingle-groupOpen-labelPrevention
Summary
This is a Phase 2, open-label, multi-cohort study to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of a single, individualized dose of HTX-011 administered into the surgical site as a monotherapy or with other medications to enhance analgesia in subjects undergoing unilateral simple bunionectomy.
Timeline
- Start
- 2018-10-24
- Primary completion
- 2019-01-31
- Completion
- 2019-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | — | Oral |
| Subject | HTX-011 | Unknown | — | Other |
Indications
No indication recorded.